文献速递产科母胎医学

英国围产期低钠血症的发病率、特征、管理与结局:基于英国产科监测系统(UKOSS)的前瞻性研究

The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS).
PubMed 文献 · BJOG · 2025-06-13

本研究采用英国产科监测系统(UKOSS)方法前瞻性观察2019年4月至2020年9月英国192家产科单位围产期低钠血症的发病率、特征、管理与结局。共提交80例,32例符合UKOSS定义,估计有症状的围产期低钠血症发病率为每10万次分娩3.0例(95%CI 2.0-4.1)。围产期低钠血症与孕产妇并发症相关,即使无记录症状,新生儿并发症和手术分娩率也较高,症状识别和记录不足可能低估了发病率。

要点

  • 有症状的围产期低钠血症发病率为每10万次分娩3.0例(95%CI 2.0-4.1)。
  • 有记录症状组与无记录症状组重症监护入院率分别为53%和24%。
  • 有记录症状组与无记录症状组新生儿入院率分别为41%和40%,自然阴道分娩率分别为38%和20%。

核心结论

  • 围产期低钠血症与孕产妇并发症相关,新生儿并发症和手术分娩率较高,即使无记录孕产妇症状也是如此。
  • 症状识别和记录不足可能低估了发病率。

研究设计与样本

  • 前瞻性观察性研究,采用英国产科监测系统(UKOSS)方法。
  • 研究设置:英国国家医疗服务体系(NHS)医院中192家由顾问医生主导的产科单位(共194家)。
  • 研究对象:英国围产期产科入院病例。
  • 方法:各单位每月向UKOSS提交病例(2019年4月至2020年9月)。
  • 病例定义:产程中或产后48小时内有症状的低钠血症(钠<125 mmol/L),排除其他原因所致症状,并排除子痫前期作为低钠血症的独立病因和潜在症状原因。

主要发现

  • 共提交80例,排除23例(10例钠≥125 mmol/L,13例子痫前期),另有25例钠<125 mmol/L但无记录症状,32例符合UKOSS定义。
  • 基于研究期间全国估计1 050 915次分娩,有记录症状的围产期低钠血症估计发病率为每10万次分娩3.0例(95%CI 2.0-4.1)。
  • 有记录症状组与无记录症状组比较:重症监护入院率53% vs 24%,新生儿入院率41% vs 40%,自然阴道分娩率38% vs 20%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 症状记录不一致,因此将有记录症状与无记录症状的病例进行比较。
  • 症状识别和记录不足可能低估了发病率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the national incidence, characteristics, management and outcomes of peripartum hyponatraemia. DESIGN: Prospective, observational study using United Kingdom (UK) Obstetric Surveillance System (UKOSS) methodology. SETTING: 192 of the 194 consultant-led obstetric units in UK National Health Service (NHS) hospitals. POPULATION: Peripartum UK obstetric admissions. METHODS: Units submitted cases monthly to UKOSS (April 2019-September 2020). The case definition was symptomatic hyponatraemia (sodium < 125 mmol/L) in labour or ≤ 48 h postpartum, excluding other causes of symptoms. Pre-eclampsia was excluded as a separate aetiology of hyponatraemia and potential cause of symptoms. As symptom documentation varied, characteristics, management and outcomes were compared between cases with and without reported symptoms. MAIN OUTCOME MEASURES: Demographics, symptoms, labour details, management and outcomes. RESULTS: Eighty cases were submitted. We excluded 23 cases (10 with sodium ≥ 125 mmol/L and 13 with pre-eclampsia). A further 25 had sodium < 125 mmol/L with no symptoms documented. Thirty-two met the UKOSS definition, resulting in an estimate of 3.0 cases of peripartum hyponatraemia with documented symptoms per 100 000 maternities (95% confidence interval 2.0-4.1), using a national estimate of 1 050 915 maternities across the study period. Characteristics and outcomes of cases with and without documented symptoms had some variation; 53% versus 24% had critical care admissions, 41% versus 40% had neonatal unit admissions, and 38% versus 20% had spontaneous vaginal birth. CONCLUSIONS: Peripartum hyponatraemia was associated with maternal morbidity. Neonatal morbidity and operative birth were high, even without documented maternal symptoms. Poor recognition and documentation of symptoms have likely underestimated the incidence.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Pillai A, Tata LJ, Lucas N, et al. The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS). BJOG. 2025. PMID: 40511476. doi:10.1111/1471-0528.18247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。